Cheap on revenue — what the screen found 2026-09-29

Among the 40 companies that passed today’s screen for "Cheap on Revenue"¹, CYH (Community Health Systems, Inc.) stands out with the lowest price-to-sales ratio at just 0.03². This metric highlights companies where revenue might be available at a bargain, but it doesn't account for profitability or earnings stability.

The screen identifies firms with low price/sales ratios, particularly those that may have negative or erratic earnings. CYH, with its $409.63M market cap³, is in the Services sector. Another notable company is WKC (World Kinect Corporation), which has a price-to-sales ratio of 0.04 and a market cap of $1.83B⁴⁵. WKC operates in Wholesale Trade.

SpyGlass Pharma, Inc. (SGP) also made the cut with a 0.05 price-to-sales ratio and a market cap of $904.43M⁶⁷, operating in Manufacturing. StoneX Group Inc. (SNEX), which has a similar price-to-sales ratio but a significantly larger market cap at $8.06B, is in the Finance, Insurance & Real Estate sector⁸.

Passing this test does not establish these companies as worth owning; it merely indicates that their revenue levels are relatively cheap compared to their stock prices. The screen doesn’t evaluate profitability or other financial health indicators, leaving out critical factors for investment decisions.

The macro regime currently shows no risk-off signals across the tracked metrics, but this does not imply any specific future performance of these screened companies.